TITLE:
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

CONDITION:
Open-Angle Glaucoma

INTERVENTION:
Glaucoma therapy

SUMMARY:

      To determine the safety and IOP-lowering ability of a test compound in patients with
      open-angle glaucoma or ocular hypertension.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Adult subjects of either sex and any race with open-angle glaucoma or ocular
             hypertension;

          -  logMAR visual acuity not worse than 0.6.

        Exclusion Criteria:

          -  Clinically relevant ophthalmic or systemic conditions may be excluded.
      
